⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001903130

Langlois Sophia J.

Reports to the SEC for 1 company · BRIDGEWATER, NJ

Transactions

7

Companies

1

Filings

4

CIK

0001903130

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+4,406 sh	—	—	8,390
2026-06-02	Keenova Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+2,685 sh	—	—	3,480
2026-06-02	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−1,289 sh	—	—	2,191
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,197 sh	—	—	6,669
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,685 sh	—	—	3,984
2026-02-23	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+3,984 sh	—	—	8,866
2025-08-14	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+4,062 sh	—	—	4,062

Recent filings

4

Accepted (ET)
Jul 174
Langlois Sophia J.0001104659-26-084781
SEC(opens sec.gov)
Jun 44
Langlois Sophia J.0001104659-26-070527
SEC(opens sec.gov)
Feb 254
Langlois Sophia D.0001104659-26-019926
SEC(opens sec.gov)
Aug 184
Langlois Sophia D.0001104659-25-079947
SEC(opens sec.gov)

Companies

1

Keenova Therapeutics plcDirector

Address

440 ROUTE 22 EAST, SUITE 302

BRIDGEWATER, NJ, 08807